- $4.18bn
- $4.35bn
- $307.54m
- 56
- 12
- 99
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 153 | 139 | 190 | 258 | 308 |
Cost of Revenue | |||||
Gross Profit | 74 | 65.1 | 99 | 138 | 152 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 175 | 186 | 228 | 277 | 351 |
Operating Profit | -22.2 | -47.1 | -37.2 | -19.5 | -43.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -22.8 | -51.8 | -51.1 | -24.1 | -43.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23 | -51.9 | -51.3 | -24.3 | -43.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -23 | -51.9 | -51.3 | -24.3 | -43.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23 | -51.9 | -51.3 | -24.3 | -43.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.04 | -2.43 | -2.06 | -0.954 | -1.54 |